Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin‐A injections improve sexual function?

Murat Topcuoğlu; Murat Can Karaburun; Arif İbiş; Mehmet İlker Gokce; Evren Süer; Omer Gülpinar

doi:10.1002/nau.25139

journal article Jan 28, 2023

Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin‐A injections improve sexual function?

Murat Topcuoğlu

Murat Can Karaburun

Arif İbiş Mehmet İlker Gokce

Evren Süer

Omer Gülpinar

Neurourology and Urodynamics Vol. 42 No. 3 pp. 607-614 · Wiley

View at Publisher Save 10.1002/nau.25139

Abstract

AbstractIntroductionInterstitial cystitis/bladder pain syndrome (IC/BPS) has a negative impact on female sexual function. We aimed to evaluate the effect of intravesical botulinum toxin‐A (BTX‐A) injection on the improvement of sexual dysfunction and urinary symptoms using the multi‐domain female sexual function Index (FSFI), interstitial cystitis symptom index (ICSI), and interstitial cystitis problem index (ICPI).Material and MethodThe data of the 23 patients (study group) who received intravesical BTX‐A with the diagnosis of IC/BPS were reviewed. Twenty‐three age‐matched healthy, sexually active women were determined as the control group. Patients received 100 U BTX‐A submucosally injections, including the trigone. One hundred units of BTX‐A were diluted to 20 cc 0.9% saline, and 1 cc was then applied submucosally on 20 different points of the bladder wall (5 U/1 mL per site). The study group was asked to fill out FSFI, ICSI, and ICPI, as well as the visual analog scale (VAS) and bladder diary before and 3 months after the treatment. Patients in the control group completed the same questionnaires once. The pre‐ and post‐treatment questionnaire scores were compared in the study group. The study group's data were also compared to the control group.ResultsCompared to the pretreatment period, the study group showed statistically significant improvement in the total FSFI score and each domain of the FSFI after BTX‐A injection. The mean total FSFI score and three domains of FSFI (desire, lubrication, pain) reached to the score of the control group following BTX‐A injection. Statistically significant improvements were also shown in scores of ICSI, ICPI, and VAS. (p < 0.05).ConclusionIC/BPS is associated with a very high incidence of sexual dysfunction. Intravesical BTX‐A injection may provide significant improvement in sexual dysfunction in women with IC/BPS.

Topics

No keywords indexed for this article. Browse by subject →

References

41

[1]

10.1016/j.ajur.2016.08.014

[2]

10.1016/s0022-5347(05)64847-1

[3]

10.1097/01.ju.0000181203.82693.95

[4]

10.1111/j.1442-2042.2008.02020.x

[5]

10.1007/s11255-014-0908-6

[6]

10.1016/j.ijgo.2011.12.015

[7]

10.1016/j.urology.2010.10.016

[8]

Zaslau S "Sexual dysfunction in patients with painful bladder syndrome" W V Med J (2008)

[9]

Gupta P "A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care" Transl Androl Urol (2015)

[10]

10.4103/iju.iju_145_20

[11]

10.1016/j.juro.2007.01.060

[12]

10.1111/j.1464-410x.2004.04796.x

[13]

10.1111/j.1743-6109.2007.00686.x

[14]

10.1007/s00192-019-04036-2

[15]

10.1016/j.urology.2004.06.073

[16]

Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment

Philip M. Hanno, Deborah Erickson, Robert Moldwin et al.

Journal of Urology 10.1016/j.juro.2015.01.086

[17]

10.1111/bju.14399

[18]

10.1016/j.ejogrb.2018.05.002

[19]

10.1007/s00345-015-1578-4

[20]

Oksuz E "Reliability and validity of the Female Sexual Function Index in Turkish population" Sendrom (2005)

[21]

10.1002/nau.24492

[22]

10.1002/nau.22760

[23]

10.1111/j.1743-6109.2004.10107.x

[24]

10.1016/j.eururo.2003.11.023

[25]

10.1001/jama.281.6.537

[26]

10.1016/j.urology.2006.12.024

[27]

10.1016/j.urology.2007.04.037

[28]

10.1111/j.1743-6109.2011.02251.x

[29]

The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores

MARKUS WIEGEL, CINDY MESTON, Raymond Rosen

Journal of Sex & Marital Therapy 10.1080/00926230590475206

[30]

10.1016/j.sxmr.2020.12.005

[31]

Webster DC "Use and effectiveness of sexual self‐care strategies for interstitial cystitis" Urol Nurs (1995)

[32]

10.1016/j.juro.2017.10.018

[33]

10.4103/aja.aja_72_19

[34]

10.5213/inj.2014.18.3.163

[35]

10.1016/j.tjog.2018.04.006

[36]

10.1111/jsm.12507

[37]

Paolucci S "Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation" Eur J Phys Rehabil Med (2016)

[38]

10.1097/00002508-200211001-00005

[39]

10.1016/s0090-4295(99)80333-1

[40]

10.12659/msm.897350

[41]

10.1016/j.eururo.2010.02.031

Cited By

7

Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan

Wan-Ru Yu, Hann-Chorng Kuo · 2023

LUTS: Lower Urinary Tract Symptoms

Metrics

7

Citations

41

References

Details

Published: Jan 28, 2023
Vol/Issue: 42(3)
Pages: 607-614
License: View

Authors

M

Murat Topcuoğlu

Department of Urology Alaaddin Keykubat University Education and Research Hospital Denizli Turkey

M

Murat Can Karaburun